Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb 3:16:25-33.
doi: 10.1016/j.csbj.2018.01.002. eCollection 2018.

FoldX as Protein Engineering Tool: Better Than Random Based Approaches?

Oliver Buß  1 , Jens Rudat  1 , Katrin Ochsenreither  1
Affiliations
Review

FoldX as Protein Engineering Tool: Better Than Random Based Approaches?

Oliver Buß et al. Comput Struct Biotechnol J. .

Abstract

Improving protein stability is an important goal for basic research as well as for clinical and industrial applications but no commonly accepted and widely used strategy for efficient engineering is known. Beside random approaches like error prone PCR or physical techniques to stabilize proteins, e.g. by immobilization, in silico approaches are gaining more attention to apply target-oriented mutagenesis. In this review different algorithms for the prediction of beneficial mutation sites to enhance protein stability are summarized and the advantages and disadvantages of FoldX are highlighted. The question whether the prediction of mutation sites by the algorithm FoldX is more accurate than random based approaches is addressed.

Keywords: Enzyme engineering; Fold-X; FoldX; Protein engineering; Protein stabilization; Thermostability.

PubMed Disclaimer

Figures

Unlabelled Image
Graphical abstract
See this image and copyright information in PMC

References

    1. Newman J.D., Turner A.P.F. Home blood glucose biosensors: a commercial perspective. Biosens Bioelectron. 2005;20:2435–2453. - PubMed
    1. Capdevila J., Elez E., Macarulla T., Ramos F.J., Ruiz-Echarri M., Tabernero J. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment. Cancer Treat Rev. 2009;35:354–363. - PubMed
    1. Bhosale S.H., Rao M.B., Deshpande V.V. Molecular and industrial aspects of glucose isomerase. Microbiol Rev. 1996;60:280–300. - PMC - PubMed
    1. Savile C.K., Janey J.M., Mundorff E.C., Moore J.C., Tam S., Jarvis W.R. Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture. Science. 2010;329:305–309. - PubMed
    1. Pollard D.J., Woodley J.M. Biocatalysis for pharmaceutical intermediates: the future is now. Trends Biotechnol. 2007;25:66–73. - PubMed

LinkOut - more resources